Biostage Alpha and Beta Analysis
| BSTGDelisted Stock | USD 4.20 0.09 2.10% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biostage. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biostage over a specified time horizon. Remember, high Biostage's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biostage's market risk premium analysis include:
Beta 0.12 | Alpha (0.57) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biostage |
Biostage Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biostage market risk premium is the additional return an investor will receive from holding Biostage long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biostage. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biostage's performance over market.| α | -0.57 | β | 0.12 |
Biostage Fundamentals Vs Peers
Comparing Biostage's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biostage's direct or indirect competition across all of the common fundamentals between Biostage and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biostage or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biostage's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biostage by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biostage to competition |
| Fundamentals | Biostage | Peer Average |
| Return On Equity | -4.92 | -0.31 |
| Return On Asset | -2.11 | -0.14 |
| Current Valuation | 78.64 M | 16.62 B |
| Shares Outstanding | 11.64 M | 571.82 M |
| Shares Owned By Insiders | 50.95 % | 10.09 % |
| Number Of Shares Shorted | 121.66 K | 4.71 M |
| Price To Earning | (0.16) X | 28.72 X |
Biostage Opportunities
Biostage Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Biostage Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biostage or other otcs. Alpha measures the amount that position in Biostage has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Biostage Upcoming Company Events
As portrayed in its financial statements, the presentation of Biostage's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biostage's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biostage's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biostage. Please utilize our Beneish M Score to check the likelihood of Biostage's management manipulating its earnings.
| 3rd of August 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View |
Build Portfolio with Biostage
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Biostage OTC Stock
If you are still planning to invest in Biostage check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostage's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |